• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Dr. Reddy's Laboratories Limited — Updates, 01-08-2026: Press Release

    01-08-2026 | 09:43 am

    Dr. Reddy's secured U.S. FDA approval for its rituximab biosimilar, significantly strengthening its global biosimilars portfolio and U.S. market presence. Fresenius Kabi will exclusively commercialize it in the U.S., boosting future revenue potential.

    No comments yet. Be the first to comment!

    All announcements from Dr. Reddy's Laboratories Limited